LWAM
Legacy Wealth Asset Management’s Gilead Sciences GILD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $830K | Sell |
7,485
-76
| -1% | -$8.43K | 0.21% | 122 |
|
|
2025
Q1 | $847K | Sell |
7,561
-190
| -2% | -$21.3K | 0.23% | 110 |
|
|
2024
Q4 | $716K | Sell |
7,751
-81
| -1% | -$7.48K | 0.19% | 156 |
|
|
2024
Q3 | $657K | Buy |
7,832
+56
| +0.7% | +$4.7K | 0.18% | 188 |
|
|
2024
Q2 | $534K | Buy |
7,776
+202
| +3% | +$13.9K | 0.15% | 216 |
|
|
2024
Q1 | $555K | Buy |
7,574
+41
| +0.5% | +$3K | 0.15% | 212 |
|
|
2023
Q4 | $610K | Buy |
7,533
+14
| +0.2% | +$1.13K | 0.2% | 168 |
|
|
2023
Q3 | $563K | Buy |
7,519
+56
| +0.8% | +$4.2K | 0.21% | 165 |
|
|
2023
Q2 | $575K | Sell |
7,463
-4,545
| -38% | -$350K | 0.2% | 172 |
|
|
2023
Q1 | $996K | Sell |
12,008
-136
| -1% | -$11.3K | 0.36% | 79 |
|
|
2022
Q4 | $1.04M | Sell |
12,144
-230
| -2% | -$19.7K | 0.4% | 75 |
|
|
2022
Q3 | $763K | Sell |
12,374
-355
| -3% | -$21.9K | 0.33% | 97 |
|
|
2022
Q2 | $787K | Sell |
12,729
-54
| -0.4% | -$3.34K | 0.32% | 125 |
|
|
2022
Q1 | $760K | Buy |
12,783
+489
| +4% | +$29.1K | 0.27% | 145 |
|
|
2021
Q4 | $893K | Buy |
12,294
+1,620
| +15% | +$118K | 0.3% | 128 |
|
|
2021
Q3 | $746K | Buy |
10,674
+419
| +4% | +$29.3K | 0.34% | 120 |
|
|
2021
Q2 | $706K | Buy |
10,255
+396
| +4% | +$27.3K | 0.31% | 131 |
|
|
2021
Q1 | $637K | Buy |
9,859
+397
| +4% | +$25.7K | 0.29% | 142 |
|
|
2020
Q4 | $551K | Buy |
+9,462
| New | +$551K | 0.28% | 150 |
|